- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Tumor Suppressor and Targeted Therapy in Hepatocellular Carcinoma: From Diagnosis to Treatment (2nd Edition)
Deadline: 30 August 2026
Targeted Therapies in Sarcomas: Overcoming Resistance and Improving Outcomes
Deadline: 8 August 2026
Circulating Tumor Cells (CTCs) and the Implementation of Liquid Biopsy (2nd Edition)
Deadline: 31 July 2026
Tumorigenesis and Tumor Microenvironment—Insights and Interventions (TTMII)
Deadline: 31 July 2026
Decoding the Tumor Microenvironment: Immune Cell–Tumor Interplay in Breast Cancer
Deadline: 31 July 2026
Microsatellite Instability in Colorectal Cancer
Deadline: 31 July 2026
Perioperative and Adjuvant Immunotherapy in Lung Cancer: New Strategies, Biomarkers, Patient Selection and Toxicity Management
Deadline: 31 July 2026
Multiple Myeloma and Immunology: From Pathophysiology to Therapy
Deadline: 31 July 2026
Tumor Microenvironment of Breast Cancer—2nd Edition
Deadline: 15 July 2026
Advances in Bacteria and Cancer
Deadline: 30 June 2026
Epigenetic Regulation in Hematologic Malignancies
Deadline: 30 June 2026
Signaling Networks Controlling Ovarian Cancer Progression and Response to Therapy
Deadline: 30 June 2026
of 15

